BioCryst Pharmaceuticals | Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Alnylam Pharmaceuticals USD 44.4M 4.15M 2025-09
BioCryst Pharmaceuticals USD 24.45M 381K 2024-12
Chugai Pharma JPY 95M 260M 2025-12
Daiichi Sankyo JPY 2.16B 1.33B 2025-12
DBV Technologies USD 461K 323.71K 2025-03
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Gilead Sciences USD 256M 2M 2025-09
GlaxoSmithKline GBP 188M 21M 2025-12
Glaxosmithkline GBP 177.95M 6.05M 2025-09
Incyte USD 582K 10K 2025-12
Ionis Pharmaceuticals USD 18M 1000K 2025-09
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
Neurocrine Biosciences USD 1.1M 0 2024-03
Novavax USD 4.24M 96K 2024-09
PTC Therapeutics USD 2.64B 2.61B 2025-09
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Ultragenyx Pharmaceutical USD 14.15M 108K 2025-09
Vertex Pharmaceuticals USD 3.3M 400K 2025-09


BioCryst Pharmaceuticals Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.